Skip to main content
Erschienen in: Obesity Surgery 2/2014

01.02.2014 | Original Contributions

Changes in Intestinal Permeability after Roux-en-Y Gastric Bypass

verfasst von: Alexandre Lages Savassi-Rocha, Marco Túlio Costa Diniz, Eduardo Garcia Vilela, Maria de Fátima Haueisen Sander Diniz, Soraya Rodrigues de Almeida Sanches, Aloísio Sales da Cunha, Maria de Lourdes de Abreu Ferrari, Henrique Oswaldo da Gama Torres, Bruno Antonio Maciente, Gabriela Santana Ataliba, Paloma Maciel Araújo, Taciana Bretas Guerra, Inara Kellen Fonseca Balbino

Erschienen in: Obesity Surgery | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Roux-en-Y gastric bypass (RYGB) interferes considerably with the anatomy and physiology of the gastrointestinal tract. The study of intestinal permeability can provide important information regarding changes in the structure and function of the mucosal barrier after the procedure.

Methods

The urinary excretion rates of lactulose and mannitol after oral intake of both substances were evaluated. We also evaluated the lactulose/mannitol excretion ratio. Tests were performed during the preoperative period (T0), at the first postoperative month (T1), and at the sixth postoperative month (T6).

Results

The study included 16 morbidly obese patients. The excretion rate of mannitol was significantly lower at T1 compared with T0 and T6 (p = 0.003). There was no significant difference in the excretion rates of lactulose or in the lactulose/mannitol ratio during the three periods. Six patients (37.5 %) exhibited a considerable increase in the excretion rate of lactulose at T6 (4–73 times higher than the preoperative value), accompanied by proportional variations in the lactulose/mannitol ratio.

Conclusions

The significant increase in mannitol excretion rate from T1 to T6 most likely reflects the occurrence of intestinal adaptation (mucosal hyperplasia), which would tend to minimize the malabsorption of macronutrients. A subgroup of patients who undergo RYGB exhibit pronounced increase in their intestinal permeability (assessed by the lactulose/mannitol ratio and the lactulose excretion rate) at T6.
Literatur
1.
Zurück zum Zitat Lonut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol. 2011;5(5):1263–82. Lonut V, Bergman RN. Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol. 2011;5(5):1263–82.
2.
Zurück zum Zitat Flancbaum L. Mechanisms of weight loss after bariatric surgery. J Laparoendosc Adv Surg Tech A. 2003;13(4):215–20. PMID: 14561249.PubMedCrossRef Flancbaum L. Mechanisms of weight loss after bariatric surgery. J Laparoendosc Adv Surg Tech A. 2003;13(4):215–20. PMID: 14561249.PubMedCrossRef
3.
Zurück zum Zitat Diniz MFHS, Passos VMA, Diniz MTC. Gut-brain communication: how does it stand after bariatric surgery? Curr Opin Clin Nutr Metab Care. 2006;9(5):629–3.PubMedCrossRef Diniz MFHS, Passos VMA, Diniz MTC. Gut-brain communication: how does it stand after bariatric surgery? Curr Opin Clin Nutr Metab Care. 2006;9(5):629–3.PubMedCrossRef
4.
Zurück zum Zitat Vilela EG, Torres HO, Ferrari ML, et al. Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res. 2008;41(12):1105–9. PMID: 19148373.PubMedCrossRef Vilela EG, Torres HO, Ferrari ML, et al. Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res. 2008;41(12):1105–9. PMID: 19148373.PubMedCrossRef
5.
Zurück zum Zitat Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol. 2008;43(7):842–8. PMID: 18584523.PubMedCrossRef Garcia Vilela E, De Lourdes De Abreu Ferrari M, Oswaldo Da Gama Torres H, et al. Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission. Scand J Gastroenterol. 2008;43(7):842–8. PMID: 18584523.PubMedCrossRef
6.
Zurück zum Zitat Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clinical science. 1992;82(5):471–88. PMID: 1317756.PubMed Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clinical science. 1992;82(5):471–88. PMID: 1317756.PubMed
7.
Zurück zum Zitat Scaldaferri F, Pizzoferrato M, Gerardi V, et al. The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol. 2012;46(Suppl):S12–7. PMID: 22955350.PubMedCrossRef Scaldaferri F, Pizzoferrato M, Gerardi V, et al. The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol. 2012;46(Suppl):S12–7. PMID: 22955350.PubMedCrossRef
8.
Zurück zum Zitat Camilleri M, Madsen K, Spiller R, et al. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24(6):503–12. PMID: 22583600.PubMedCrossRef Camilleri M, Madsen K, Spiller R, et al. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24(6):503–12. PMID: 22583600.PubMedCrossRef
9.
Zurück zum Zitat Gaggiotti G, Catassi C, Sgattoni C, et al. Modifications of intestinal permeability test induced by biliopancreatic diversion: preliminary results. Obes Surg. 1995;5(4):424–6. PMID: 10733839.PubMedCrossRef Gaggiotti G, Catassi C, Sgattoni C, et al. Modifications of intestinal permeability test induced by biliopancreatic diversion: preliminary results. Obes Surg. 1995;5(4):424–6. PMID: 10733839.PubMedCrossRef
10.
Zurück zum Zitat Sigalet DL, Martin GR, Poole A. Differential sugar absorption as a marker for adaptation in short bowel syndrome. J Pediatr Surg. 2000;35(5):661–4.PubMedCrossRef Sigalet DL, Martin GR, Poole A. Differential sugar absorption as a marker for adaptation in short bowel syndrome. J Pediatr Surg. 2000;35(5):661–4.PubMedCrossRef
11.
Zurück zum Zitat Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92(4):704–13. PMID: 20739420.PubMedCrossRef Odstrcil EA, Martinez JG, Santa Ana CA, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92(4):704–13. PMID: 20739420.PubMedCrossRef
12.
Zurück zum Zitat Seva-Pereira G, Lopes LR, Brandalise NA, et al. Fat absorption after total gastrectomy in rats submitted to Roux-en-Y or Rosanov-like double-transit technique. Acta Cir Bras. 2006;21(6):380–4. PMID: 17160249.PubMedCrossRef Seva-Pereira G, Lopes LR, Brandalise NA, et al. Fat absorption after total gastrectomy in rats submitted to Roux-en-Y or Rosanov-like double-transit technique. Acta Cir Bras. 2006;21(6):380–4. PMID: 17160249.PubMedCrossRef
13.
Zurück zum Zitat Ponsky TA, Brody F, Pucci E. Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass. J Am Coll Surg. 2005;201(1):125–31. PMID: 15978453.PubMedCrossRef Ponsky TA, Brody F, Pucci E. Alterations in gastrointestinal physiology after Roux-en-Y gastric bypass. J Am Coll Surg. 2005;201(1):125–31. PMID: 15978453.PubMedCrossRef
14.
Zurück zum Zitat Leth RD, Abrahamsson H, Kilander A, et al. Malabsorption of fat after partial gastric resection. A study of pathophysiologic mechanisms. Eur J Surg Acta chir. 1991;157(3):205–8. Leth RD, Abrahamsson H, Kilander A, et al. Malabsorption of fat after partial gastric resection. A study of pathophysiologic mechanisms. Eur J Surg Acta chir. 1991;157(3):205–8.
15.
16.
Zurück zum Zitat Savassi-Rocha AL, Diniz MT, Savassi-Rocha PR, et al. Influence of jejunoileal and common limb length on weight loss following Roux-en-Y gastric bypass. Obes Surg. 2008;18(11):1364–8. PMID: 18459021.PubMedCrossRef Savassi-Rocha AL, Diniz MT, Savassi-Rocha PR, et al. Influence of jejunoileal and common limb length on weight loss following Roux-en-Y gastric bypass. Obes Surg. 2008;18(11):1364–8. PMID: 18459021.PubMedCrossRef
17.
Zurück zum Zitat Stefanidis D, Kuwada TS, Gersin KS. The importance of the length of the limbs for gastric bypass patients—an evidence-based review. Obes Surg. 2011;21(1):119–24. PMID: 20680504.PubMedCrossRef Stefanidis D, Kuwada TS, Gersin KS. The importance of the length of the limbs for gastric bypass patients—an evidence-based review. Obes Surg. 2011;21(1):119–24. PMID: 20680504.PubMedCrossRef
18.
Zurück zum Zitat Orci L, Chilcott M, Huber O. Short versus long Roux-limb length in Roux-en-Y gastric bypass surgery for the treatment of morbid and super obesity: a systematic review of the literature. Obes Surg. 2011;21(6):797–804. PMID: 21479976.PubMedCrossRef Orci L, Chilcott M, Huber O. Short versus long Roux-limb length in Roux-en-Y gastric bypass surgery for the treatment of morbid and super obesity: a systematic review of the literature. Obes Surg. 2011;21(6):797–804. PMID: 21479976.PubMedCrossRef
19.
Zurück zum Zitat Cisler JJ, Buchman AL. Intestinal adaptation in short bowel syndrome. J Investig Med. 2005;53(8):402–13. PMID: 16354579.PubMedCrossRef Cisler JJ, Buchman AL. Intestinal adaptation in short bowel syndrome. J Investig Med. 2005;53(8):402–13. PMID: 16354579.PubMedCrossRef
20.
Zurück zum Zitat Fenyo G. Morphological changes of the adapting small intestine deprived of gastric, duodenal, biliary and pancreatic secretions in the rat. Eur Surg Res. 1977;9(2):122–30. PMID: 856595.PubMedCrossRef Fenyo G. Morphological changes of the adapting small intestine deprived of gastric, duodenal, biliary and pancreatic secretions in the rat. Eur Surg Res. 1977;9(2):122–30. PMID: 856595.PubMedCrossRef
21.
Zurück zum Zitat Taqi E, Wallace LE, de Heuvel E, et al. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg. 2010;45(5):987–95. PMID: 20438940.PubMedCrossRef Taqi E, Wallace LE, de Heuvel E, et al. The influence of nutrients, biliary-pancreatic secretions, and systemic trophic hormones on intestinal adaptation in a Roux-en-Y bypass model. J Pediatr Surg. 2010;45(5):987–95. PMID: 20438940.PubMedCrossRef
22.
Zurück zum Zitat Albert V, Young GP, Morton CL, et al. Systemic factors are trophic in bypassed rat small intestine in the absence of luminal contents. Gut. 1990;31(3):311–6. PMID: 2323595.PubMedCrossRef Albert V, Young GP, Morton CL, et al. Systemic factors are trophic in bypassed rat small intestine in the absence of luminal contents. Gut. 1990;31(3):311–6. PMID: 2323595.PubMedCrossRef
23.
Zurück zum Zitat Miedema BW, Kelly KA, Camilleri M, et al. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology. 1992;103(4):1133–43. PMID: 1397870.PubMed Miedema BW, Kelly KA, Camilleri M, et al. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology. 1992;103(4):1133–43. PMID: 1397870.PubMed
24.
Zurück zum Zitat Seyfried F, Lannoo M, Gsell W, et al. Roux-en-Y gastric bypass in mice—surgical technique and characterisation. Obes Surg. 2012;22(7):1117–25. PMID: 22527601.PubMedCrossRef Seyfried F, Lannoo M, Gsell W, et al. Roux-en-Y gastric bypass in mice—surgical technique and characterisation. Obes Surg. 2012;22(7):1117–25. PMID: 22527601.PubMedCrossRef
25.
Zurück zum Zitat Suzuki S, Ramos EJ, Gonçalves CG, et al. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery. 2005;138(2):283–90.PubMedCrossRef Suzuki S, Ramos EJ, Gonçalves CG, et al. Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model. Surgery. 2005;138(2):283–90.PubMedCrossRef
26.
Zurück zum Zitat Wang G, Agenor K, Pizot J, et al. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (BGP). Obes Surg. 2012;22:1263–7.PubMedCentralPubMedCrossRef Wang G, Agenor K, Pizot J, et al. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (BGP). Obes Surg. 2012;22:1263–7.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Ardila-Hani A, Soffer EE. Review article: the impact of bariatric surgery on gastrointestinal motility. Aliment Pharmacol Ther. 2011;34(8):825–31. PMID: 21854401.PubMedCrossRef Ardila-Hani A, Soffer EE. Review article: the impact of bariatric surgery on gastrointestinal motility. Aliment Pharmacol Ther. 2011;34(8):825–31. PMID: 21854401.PubMedCrossRef
28.
Zurück zum Zitat Zhang YM, Liu XL, Xue DB, et al. Myoelectric activity and motility of the Roux limb after cut or uncut Roux-en-Y gastrojejunostomy. World J Gastroenterol. 2006;12(47):7699–704. PMID: 17171803.PubMed Zhang YM, Liu XL, Xue DB, et al. Myoelectric activity and motility of the Roux limb after cut or uncut Roux-en-Y gastrojejunostomy. World J Gastroenterol. 2006;12(47):7699–704. PMID: 17171803.PubMed
29.
Zurück zum Zitat Spak E, Bjorklund P, Helander HF, et al. Changes in the mucosa of the Roux-limb after gastric bypass surgery. Histopathology. 2010;57(5):680–8. PMID: 21054493.PubMedCrossRef Spak E, Bjorklund P, Helander HF, et al. Changes in the mucosa of the Roux-limb after gastric bypass surgery. Histopathology. 2010;57(5):680–8. PMID: 21054493.PubMedCrossRef
30.
Zurück zum Zitat Benjamin MA, McKay DM, Yang PC, et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut. 2000;47:112–9.PubMedCrossRef Benjamin MA, McKay DM, Yang PC, et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut. 2000;47:112–9.PubMedCrossRef
31.
Zurück zum Zitat Moran GW, O'Neill C, McLaughlin JT. GLP-2 enhances barrier formation and attenuates TNFalpha-induced changes in a Caco-2 cell model of the intestinal barrier. Regul Pept. 2012;178(1–3):95–101. PMID: 22809889.PubMedCrossRef Moran GW, O'Neill C, McLaughlin JT. GLP-2 enhances barrier formation and attenuates TNFalpha-induced changes in a Caco-2 cell model of the intestinal barrier. Regul Pept. 2012;178(1–3):95–101. PMID: 22809889.PubMedCrossRef
32.
Zurück zum Zitat Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2 driven improvement of gut permeability. Gut. 2009;58:1091–103.PubMedCentralPubMedCrossRef Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2 driven improvement of gut permeability. Gut. 2009;58:1091–103.PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat leRoux CW, Borg C, Wallis K, et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg. 2010;252(1):50–6.CrossRef leRoux CW, Borg C, Wallis K, et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg. 2010;252(1):50–6.CrossRef
34.
Zurück zum Zitat Ljungmann K, Hartmann B, Kissmeyer-Nielsen P, et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol. 2001;281(3):G779–85. PMID: 11518690.PubMed Ljungmann K, Hartmann B, Kissmeyer-Nielsen P, et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol. 2001;281(3):G779–85. PMID: 11518690.PubMed
35.
Zurück zum Zitat Jeppesen PB. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012;5(3):159–71. PMID: 22570676.PubMedCentralPubMedCrossRef Jeppesen PB. Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome. Therap Adv Gastroenterol. 2012;5(3):159–71. PMID: 22570676.PubMedCentralPubMedCrossRef
36.
Zurück zum Zitat Sigalet DL, Lam V, Boctor D. The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function. Semin Pediatr Surg. 2010;19(1):44–9. PMID: 20123273.PubMedCrossRef Sigalet DL, Lam V, Boctor D. The assessment, and glucagon-like peptide-2 modulation, of intestinal absorption and function. Semin Pediatr Surg. 2010;19(1):44–9. PMID: 20123273.PubMedCrossRef
37.
Zurück zum Zitat Sinclair EM, Drucker DJ. Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology (Bethesda). 2005;20:357–65. PMID: 16174875.CrossRef Sinclair EM, Drucker DJ. Proglucagon-derived peptides: mechanisms of action and therapeutic potential. Physiology (Bethesda). 2005;20:357–65. PMID: 16174875.CrossRef
38.
Zurück zum Zitat Moreira AP, Texeira TF, Ferreira AB, et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxemia. Br J Nutr. 2012;108(5):801–9.PubMedCrossRef Moreira AP, Texeira TF, Ferreira AB, et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxemia. Br J Nutr. 2012;108(5):801–9.PubMedCrossRef
39.
Zurück zum Zitat Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN Journal of Parenteral and Enteral Nutrition. 2011;35(5 Suppl):14S–20S. PMID: 21807932.PubMedCrossRef Frazier TH, DiBaise JK, McClain CJ. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN Journal of Parenteral and Enteral Nutrition. 2011;35(5 Suppl):14S–20S. PMID: 21807932.PubMedCrossRef
40.
Zurück zum Zitat Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22:950–55.PubMedCrossRef Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, et al. Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-alpha and interleukin-6 after bariatric surgery. Obes Surg. 2012;22:950–55.PubMedCrossRef
41.
Zurück zum Zitat Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery. 2012;151(4):587–93. PMID: 22088821.PubMedCrossRef Monte SV, Caruana JA, Ghanim H, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery. 2012;151(4):587–93. PMID: 22088821.PubMedCrossRef
42.
Zurück zum Zitat Moschen AR, Molnar C, Geiger S, et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut. 2010;59(9):1259–64. PMID: 20660075.PubMedCrossRef Moschen AR, Molnar C, Geiger S, et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut. 2010;59(9):1259–64. PMID: 20660075.PubMedCrossRef
43.
Zurück zum Zitat Dalmas E, Rouault C, Abdennour M, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94(2):450–8. PMID: 21677057.PubMedCrossRef Dalmas E, Rouault C, Abdennour M, et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. Am J Clin Nutr. 2011;94(2):450–8. PMID: 21677057.PubMedCrossRef
44.
Zurück zum Zitat Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alfa receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67(5):679–86.PubMedCrossRef Vilarrasa N, Vendrell J, Sánchez-Santos R, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alfa receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol (Oxf). 2007;67(5):679–86.PubMedCrossRef
45.
Zurück zum Zitat Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7(5):618–24. PMID: 21546319.PubMedCrossRef Miller GD, Nicklas BJ, Fernandez A. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2011;7(5):618–24. PMID: 21546319.PubMedCrossRef
46.
Zurück zum Zitat Morinigo R, Casamitjana R, Delgado S, et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care. 2007;30(7):1906–8. PMID: 17468354.PubMedCrossRef Morinigo R, Casamitjana R, Delgado S, et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care. 2007;30(7):1906–8. PMID: 17468354.PubMedCrossRef
47.
Zurück zum Zitat Joao Cabrera E, Valezi AC, Delfino VD, et al. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass. Obes Surg. 2010;20(1):42–9. PMID: 19826889.PubMedCrossRef Joao Cabrera E, Valezi AC, Delfino VD, et al. Reduction in plasma levels of inflammatory and oxidative stress indicators after Roux-en-Y gastric bypass. Obes Surg. 2010;20(1):42–9. PMID: 19826889.PubMedCrossRef
48.
Zurück zum Zitat Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084–96.PubMedCrossRef Jacobsen SH, Olesen SC, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg. 2012;22(7):1084–96.PubMedCrossRef
49.
Zurück zum Zitat Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198–204. PMID: 19381735.PubMedCrossRef Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198–204. PMID: 19381735.PubMedCrossRef
50.
Zurück zum Zitat Machado JD, Campos CS, Lopes Dah Silva C, et al. Intestinal bacterial overgrowth after Roux-en-Y gastric bypass. Obes Surg. 2008;18(1):139–43. PMID: 18080824.PubMedCrossRef Machado JD, Campos CS, Lopes Dah Silva C, et al. Intestinal bacterial overgrowth after Roux-en-Y gastric bypass. Obes Surg. 2008;18(1):139–43. PMID: 18080824.PubMedCrossRef
51.
Zurück zum Zitat Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28(5):293–8. PMID: 19083422.PubMedCrossRef Lakhani SV, Shah HN, Alexander K, et al. Small intestinal bacterial overgrowth and thiamine deficiency after Roux-en-Y gastric bypass surgery in obese patients. Nutr Res. 2008;28(5):293–8. PMID: 19083422.PubMedCrossRef
52.
Zurück zum Zitat Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049–57. PMID: 20876719.PubMedCrossRef Furet JP, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049–57. PMID: 20876719.PubMedCrossRef
53.
Zurück zum Zitat Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17(6):752–8. PMID: 17879574.PubMedCrossRef Ishida RK, Faintuch J, Paula AM, et al. Microbial flora of the stomach after gastric bypass for morbid obesity. Obes Surg. 2007;17(6):752–8. PMID: 17879574.PubMedCrossRef
54.
Zurück zum Zitat Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial–host metabolic cross-talk. Gut. 2011;60(9):1214–23. PMID: 21572120.PubMedCentralPubMedCrossRef Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial–host metabolic cross-talk. Gut. 2011;60(9):1214–23. PMID: 21572120.PubMedCentralPubMedCrossRef
55.
Zurück zum Zitat Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9(10):590–8. PMID: 22926153.PubMedCrossRef Aron-Wisnewsky J, Dore J, Clement K. The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2012;9(10):590–8. PMID: 22926153.PubMedCrossRef
56.
Zurück zum Zitat Riordan SM, McIver CJ, Wakefield D, et al. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand J Gastroenterol. 1996;31(10):977–84. PMID: 8898418.PubMedCrossRef Riordan SM, McIver CJ, Wakefield D, et al. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand J Gastroenterol. 1996;31(10):977–84. PMID: 8898418.PubMedCrossRef
57.
Zurück zum Zitat Morris TH, Sorensen SH, Turkington J, et al. Diarrhoea and increased intestinal permeability in laboratory beagles associated with proximal small intestinal bacterial overgrowth. Lab Anim. 1994;28(4):313–9. PMID: 7830370.PubMedCrossRef Morris TH, Sorensen SH, Turkington J, et al. Diarrhoea and increased intestinal permeability in laboratory beagles associated with proximal small intestinal bacterial overgrowth. Lab Anim. 1994;28(4):313–9. PMID: 7830370.PubMedCrossRef
58.
Zurück zum Zitat Batt RM, Hall EJ, McLean L, et al. Small intestinal bacterial overgrowth and enhanced intestinal permeability in healthy beagles. Am J Vet Res. 1992;53(10):1935–40. PMID: 1456544.PubMed Batt RM, Hall EJ, McLean L, et al. Small intestinal bacterial overgrowth and enhanced intestinal permeability in healthy beagles. Am J Vet Res. 1992;53(10):1935–40. PMID: 1456544.PubMed
59.
Zurück zum Zitat Rutgers HC, Batt RM, Proud FJ, et al. Intestinal permeability and function in dogs with small intestinal bacterial overgrowth. J Small Anim Pract. 1996;37(9):428–34. PMID: 8887203.PubMedCrossRef Rutgers HC, Batt RM, Proud FJ, et al. Intestinal permeability and function in dogs with small intestinal bacterial overgrowth. J Small Anim Pract. 1996;37(9):428–34. PMID: 8887203.PubMedCrossRef
60.
Zurück zum Zitat Lauritano EC, Valenza V, Sparano L, et al. Small intestinal bacterial overgrowth and intestinal permeability. Scand J Gastroenterol. 2010;45(9):1131–2. PMID: 20443749.PubMedCrossRef Lauritano EC, Valenza V, Sparano L, et al. Small intestinal bacterial overgrowth and intestinal permeability. Scand J Gastroenterol. 2010;45(9):1131–2. PMID: 20443749.PubMedCrossRef
61.
Zurück zum Zitat Riordan SM, McIver CJ, Williams R. Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol. 1998;93(2):234–7. PMID: 9468250.PubMedCrossRef Riordan SM, McIver CJ, Williams R. Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol. 1998;93(2):234–7. PMID: 9468250.PubMedCrossRef
62.
Zurück zum Zitat Riordan SM, McIver CJ, Thomas DH, et al. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol. 1997;32(6):556–63. PMID: 9200287.PubMedCrossRef Riordan SM, McIver CJ, Thomas DH, et al. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol. 1997;32(6):556–63. PMID: 9200287.PubMedCrossRef
63.
Zurück zum Zitat Drenick EJ, Roslyn JJ. Cure of arthritis-dermatitis syndrome due to intestinal bypass by resection of nonfunctional segment of blind loop. Dig Dis Sci. 1990;35(5):656–60.PubMedCrossRef Drenick EJ, Roslyn JJ. Cure of arthritis-dermatitis syndrome due to intestinal bypass by resection of nonfunctional segment of blind loop. Dig Dis Sci. 1990;35(5):656–60.PubMedCrossRef
64.
Zurück zum Zitat Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol. 2011;52(1):e5–7. PMID: 21332683.PubMedCrossRef Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Australas J Dermatol. 2011;52(1):e5–7. PMID: 21332683.PubMedCrossRef
Metadaten
Titel
Changes in Intestinal Permeability after Roux-en-Y Gastric Bypass
verfasst von
Alexandre Lages Savassi-Rocha
Marco Túlio Costa Diniz
Eduardo Garcia Vilela
Maria de Fátima Haueisen Sander Diniz
Soraya Rodrigues de Almeida Sanches
Aloísio Sales da Cunha
Maria de Lourdes de Abreu Ferrari
Henrique Oswaldo da Gama Torres
Bruno Antonio Maciente
Gabriela Santana Ataliba
Paloma Maciel Araújo
Taciana Bretas Guerra
Inara Kellen Fonseca Balbino
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 2/2014
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-013-1084-y

Weitere Artikel der Ausgabe 2/2014

Obesity Surgery 2/2014 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.